Value-Generating Exploratory Trials in Neurodegenerative Dementias
Sign Up to like & getrecommendations! Published in 2021 at "Neurology"
DOI: 10.1212/wnl.0000000000011774
Abstract: Drug development for Alzheimer disease and other neurodegenerative dementias, including frontotemporal dementia, has experienced a long history of phase 2 and phase 3 clinical trials that failed to show efficacy of investigational drugs. Despite differences… read more here.
Keywords: development; trials neurodegenerative; exploratory trials; value generating ... See more keywords